Type of Intervention: Specific Action
Sectors Involved: Health, Research and Development
Level of Jurisdiction: National
Lead People/Agency: Ministry of Health and Ministry of Science and Innovation
Overview: The National Center for Microbiology investigates the SARS-CoV2 virus and the COVID-19 disease in a holistic and integrative manner.
The Health Institute Carlos III, through the National Center for Microbiology (CNM-ISCIII), has approved the launch of a research project to try to provide an integrative response to COVID-19. For the project, titled “Coordination of research activities at the CNM to carry out an integrative response to the SARS-CoV2 pandemic in Spain”, 12 different research groups from the CNM-ISCIII will be coordinated by Inmaculada Casas, responsible for the Respiratory Viruses and Flu Unit (VRP) and director of the WHO National Flu Center in Madrid.
This is an unprecedented cooperation in the CNM that will bring together the experience of this number of groups, ranging from virological surveillance, knowledge of the virus and the response of specific anti-SARS-CoV2 antibodies, to the development of their own technology, validation of the existing technologies, application of a vaccine prototype and study of predictive biomarkers of the evolution of the disease in patients with different clinical manifestations, without forgetting the automation of different processes.
Full details here: https://www.ciencia.gob.es/portal/site/MICINN/menuitem.edc7f2029a2be27d7010721001432ea0/?vgnextoid=cc8a48505e392710VgnVCM1000001d04140aRCRD&vgnextchannel=4346846085f90210VgnVCM1000001034e20aRCRD&lang_choosen=en
Type of Justification: Scientific Evidence (e.g. academic paper, report)
Source of Evidence or Justification: National – academic